PROGRAM

12.00h Lunch and poster session

13.00h WELCOME

13.05h Keynote talk on FUNDAMENTAL cancer researchProf. Wim Vanden Berghe: Team leader at PPES (Protein chemistry, proteomics and epigenetic signalling), Faculty of pharmaceutical, biomedical and veterinary sciences)

13.30h Keynote talk on TRANSLATIONAL cancer researchProf. Evelien Smits: MIPRO (Moleculaire Beeldvorming, Pathologie, Radiotherapie, Oncologie), Faculty of Medicine and Health Sciences

13.55h Keynote talk on CLINICAL cancer researchProf. Hans Prenen: Head of UNICCRA (University Clinical Research Center Antwerp) at UZA, Faculty of Medicine and Health Sciences

14.20h COFFEE BREAK

14.40h Cancer research at UAntwerpProf. Steven Van Laere: Resp. Manager of the Oncology Spearhead at the Faculty of Medicine and Health Sciences Dr. Debbie Le Blon: research manager at Center of Excellence IPPON (Integrated Personalized and Precision Oncology Network)

14.55h Presentations, Part1
Elise Daems: A novel singlet oxygen-based photoelectrochemical platform for the specific detection of KRAS mutations
Lore Dams: Biopsychosocial risk factors for pain and pain-related disability one year after surgery for breast cancer​
Toon Van Genechten: Adjuvant Wilms Tumor 1 specific dendritic cell immunotherapy complementing conventional therapy for pediatric patients with hig-grade glioma and diffuse intrinsic pontine glioma (ADDICT-pedGLIO): a phase 1/2 clinical trial
Maxime De Laere: The UZA/UAntwerp Patient Advisory Committee for oncological research – Where do we stand now?
Ana Regina de Abreu: The potential of genome-wide DNA methylation sequencing methods for biomarker discovery in cancer

16.10h COFFEE BREAK

16.25h Presentations, Part2
Sofia Peeters: Development of a patient-derived tumor organoid therapy screening model for predicting clinical therapy response in gastrointestinal cancer patients
Karuna Adhikari: Development and pre-clinical evaluation of an 18F-labeled d-TCO derivative for biorthogonal pretargeted PET imaging of cancer
Lilu Ding: Effectiveness of organized mammography screening for different breast cancer molecular subtypes
Eline Berghmans: Towards a better prediction of anti-PD-(L)1 immunotherapy response in lung cancer (NSCLC) patients: a proteomic approach
Verdi Vanreusel: The quest for a dosimetric solution in pre-clinical FLASH radiotherapy

​17.40h CLOSING WORDS